In hepatoma cells, tumorigenic TGFβ activity is switched to a tumor-suppressive activity when FGFR is inhibited, suggesting crosstalk between FGFR and TGFBR activity promotes TGFβ-mediated malignancy [333]. This evidence concerns the gene TGFB1 and hepatocellular carcinoma.